- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1374
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1374 companies
Hubei Hongyuan Pharmaceutical Technology
Market Cap: CN¥5.6b
Engages in the production and sale of pharmaceutical products in China and internationally.
301246
CN¥14.20
7D
-1.7%
1Y
10.8%
Tong Ren Tang Technologies
Market Cap: HK$6.1b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.79
7D
-2.6%
1Y
-11.1%
Mochida Pharmaceutical
Market Cap: JP¥117.0b
Manufactures and sells pharmaceuticals and healthcare products in Japan.
4534
JP¥3,300.00
7D
1.4%
1Y
-3.8%
Relay Therapeutics
Market Cap: US$779.3m
Operates as a clinical-stage precision medicines company.
RLAY
US$4.38
7D
-3.7%
1Y
-40.8%
Akums Drugs and Pharmaceuticals
Market Cap: ₹68.4b
Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.
AKUMS
₹446.65
7D
-6.3%
1Y
-46.4%
Iovance Biotherapeutics
Market Cap: US$767.1m
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.
IOVA
US$2.02
7D
-8.2%
1Y
-78.2%
Beijing Science Sun Pharmaceutical
Market Cap: CN¥5.4b
A biopharmaceutical company, engages in the research and development, production, and sales of injections in China.
300485
CN¥11.30
7D
-6.5%
1Y
59.2%
Niagen Bioscience
Market Cap: US$760.8m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$9.41
7D
-7.2%
1Y
148.9%
Takara Bio
Market Cap: JP¥113.4b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥942.00
7D
-1.2%
1Y
-9.6%
Septerna
Market Cap: US$753.9m
A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.
SEPN
US$16.75
7D
5.1%
1Y
n/a
Shanghai Xiao Fang PharmaceuticalLtd
Market Cap: CN¥5.4b
Shanghai Xiao Fang Pharmaceutical Co., Ltd produces and sells medicines in China.
603207
CN¥33.41
7D
-5.8%
1Y
39.7%
Jiangsu Lianhuan Pharmaceutical
Market Cap: CN¥5.4b
Manufactures and sells pharmaceuticals, preparations, and API products in China and internationally.
600513
CN¥18.76
7D
-6.4%
1Y
111.5%
Mind Medicine (MindMed)
Market Cap: US$747.2m
A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.
MNMD
US$9.77
7D
3.1%
1Y
65.9%
Xencor
Market Cap: US$746.8m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.
XNCR
US$10.33
7D
3.0%
1Y
-49.5%
Chong Kun Dang Pharmaceutical
Market Cap: ₩1.1t
Engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.
A185750
₩79,800.00
7D
-3.9%
1Y
-26.8%
Hunan Fangsheng Pharmaceutical
Market Cap: CN¥5.3b
Engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China.
603998
CN¥12.08
7D
12.1%
1Y
10.5%
Akebia Therapeutics
Market Cap: US$734.5m
A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.
AKBA
US$2.71
7D
-8.4%
1Y
103.8%
Hinova Pharmaceuticals
Market Cap: CN¥5.2b
A clinical-stage pharmaceutical company, engages in the development and production of therapeutics for cancers and metabolic syndromes.
688302
CN¥52.78
7D
-1.6%
1Y
72.0%
ArriVent BioPharma
Market Cap: US$724.6m
A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.
AVBP
US$17.17
7D
-7.6%
1Y
-27.0%
Hefei Lifeon Pharmaceutical
Market Cap: CN¥5.1b
Engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients.
003020
CN¥27.03
7D
-5.0%
1Y
47.6%
Guizhou Sanli PharmaceuticalLtd
Market Cap: CN¥5.1b
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products.
603439
CN¥12.65
7D
-3.1%
1Y
-9.4%
Myriad Genetics
Market Cap: US$718.3m
A molecular diagnostic testing and precision medicine company, develops and provides molecular tests.
MYGN
US$7.76
7D
1.0%
1Y
-70.4%
Fuan Pharmaceutical (Group)
Market Cap: CN¥5.1b
Research and develops, produces, and sells chemical drugs in the People's Republic of China.
300194
CN¥4.29
7D
-2.9%
1Y
2.6%
R&G PharmaStudies
Market Cap: CN¥5.1b
Operates as a clinical trial outsourcing service provider in China and internationally.
301333
CN¥53.46
7D
-4.1%
1Y
22.2%
Basilea Pharmaceutica
Market Cap: CHF 565.8m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 45.20
7D
-5.3%
1Y
-2.8%
Tibet Weixinkang Medicine
Market Cap: CN¥5.0b
Engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China.
603676
CN¥11.62
7D
-2.0%
1Y
39.2%
Day One Biopharmaceuticals
Market Cap: US$703.7m
A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
DAWN
US$6.68
7D
-7.4%
1Y
-53.3%
Maravai LifeSciences Holdings
Market Cap: US$694.6m
A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
MRVI
US$2.69
7D
-6.6%
1Y
-67.8%
Zhejiang Orient Gene Biotech
Market Cap: CN¥4.9b
Researches and develops, produces, and sells in vitro diagnostic products worldwide.
688298
CN¥25.53
7D
-2.0%
1Y
-17.1%
Elite Pharmaceuticals
Market Cap: US$681.6m
A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.
ELTP
US$0.63
7D
-3.8%
1Y
60.7%
Tyra Biosciences
Market Cap: US$680.1m
A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.
TYRA
US$12.54
7D
-2.0%
1Y
-46.4%
Thalys Medical Technology Group
Market Cap: CN¥4.8b
Provides intensive operation services of medical inspection in China.
603716
CN¥25.65
7D
-10.8%
1Y
297.1%
Gyre Therapeutics
Market Cap: US$669.4m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$7.29
7D
-5.2%
1Y
-43.0%
Nurix Therapeutics
Market Cap: US$665.1m
A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.
NRIX
US$8.33
7D
-7.1%
1Y
-64.1%
Zhejiang Starry PharmaceuticalLtd
Market Cap: CN¥4.7b
Engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally.
603520
CN¥10.81
7D
-5.8%
1Y
22.8%
Zentiva
Market Cap: RON 3.2b
Engages in the production and marketing of preparations and medicines for human use in Romania and internationally.
SCD
RON 4.52
7D
0%
1Y
55.9%